These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30001785)

  • 41. Cost-effectiveness of Virtual Bone Strength Testing in Osteoporosis Screening Programs for Postmenopausal Women in the United States.
    Agten CA; Ramme AJ; Kang S; Honig S; Chang G
    Radiology; 2017 Nov; 285(2):506-517. PubMed ID: 28613988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.
    Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B
    Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Are bones in HIV-infected patient really fragile?].
    Biver E; Ciaffi L; Rizzoli R; Calmy A
    Rev Med Suisse; 2013 Jun; 9(390):1246-50. PubMed ID: 23821841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Osteoporosis: a clinical perspective].
    Matikainen N
    Duodecim; 2016; 132(11):1051-8. PubMed ID: 27400591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Agreement of Mexican FRAX with and without the value of bone mineral density in assessing the risk of fracture in daily clinical practice.
    Horta-Baas G; Pérez Bolde-Hernández A; Pérez-Pérez A; Vergara-Sánchez I; Romero-Figueroa MDS
    Med Clin (Barc); 2017 May; 148(9):387-393. PubMed ID: 28118961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges in the Screening and Management of Osteoporosis.
    LaVallee LA; Scott MA; Hulkower SD
    N C Med J; 2016; 77(6):416-419. PubMed ID: 27864493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for osteoporosis in men aged 70 years and older in a primary care setting in the United States.
    Lim SY; Lim JH; Nguyen D; Okamura R; Amiri HM; Calmes M; Nugent K
    Am J Mens Health; 2013 Jul; 7(4):350-4. PubMed ID: 23440083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Swiss guidance for the diagnosis and management of osteoporosis].
    Kraenzlin ME
    Rev Med Suisse; 2013 Jun; 9(390):1272, 1274-8. PubMed ID: 23821846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is there an interaction between socioeconomic status and FRAX 10-year fracture probability determined with and without bone density measures? Data from the Geelong Osteoporosis Study of female cohort.
    Brennan SL; Quirk SE; Hosking SM; Kotowicz MA; Holloway KL; Moloney DJ; Dobbins AG; Pasco JA
    Calcif Tissue Int; 2015 Feb; 96(2):138-44. PubMed ID: 25578145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Underdiagnosis and Undertreatment of Osteoporosis: The Battle to Be Won.
    Miller PD
    J Clin Endocrinol Metab; 2016 Mar; 101(3):852-9. PubMed ID: 26909798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of FRAX(®) in men.
    Harvey NC; McCloskey E; Kanis JA
    Joint Bone Spine; 2016 Oct; 83(5):477-8. PubMed ID: 27269654
    [No Abstract]   [Full Text] [Related]  

  • 52. Screening for osteoporosis.
    Croswell J
    Am Fam Physician; 2011 May; 83(10):1201-2. PubMed ID: 21568255
    [No Abstract]   [Full Text] [Related]  

  • 53. Underuse and Overuse of Osteoporosis Screening in a Regional Health System: a Retrospective Cohort Study.
    Amarnath AL; Franks P; Robbins JA; Xing G; Fenton JJ
    J Gen Intern Med; 2015 Dec; 30(12):1733-40. PubMed ID: 25986135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osteoporosis: What about men?
    Farford B; Balog J; Jackson KD; Montero D
    J Fam Pract; 2015 Sep; 64(9):542-52. PubMed ID: 26546951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and management of osteoporosis.
    Ralston SH; Fraser J
    Practitioner; 2015 Dec; 259(1788):15-9, 2. PubMed ID: 26882774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are hospitalized patients with fragile fractures managed properly in relation to underlying osteoporosis?
    Mehrpour SR; Aghamirsalim MR; Sorbi R
    J Clin Rheumatol; 2012 Apr; 18(3):122-4. PubMed ID: 22426584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Worldwide Fracture Prediction.
    El-Hajj Fuleihan G; Chakhtoura M; Cauley JA; Chamoun N
    J Clin Densitom; 2017; 20(3):397-424. PubMed ID: 28734709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RECOMMENDATIONS BY GEORGIAN ASSOCIATION OF SKELETAL METABOLIC DISEASES ON THE INITIATION OF TREATMENT WITH USE OF AGE-DEPENDENT INTERVENTION THRESHOLD BASED ON FRAX IN PATIENTS WITH OSTEOPOROSIS.
    Giorgadze E; Tsagareli M; Lomidze M; Sulikashvili T; Jeiranashvili N; Uridia N
    Georgian Med News; 2019 Jun; (291):89-93. PubMed ID: 31418738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-participation in systematic screening for osteoporosis-the ROSE trial.
    Rothmann MJ; Möller S; Holmberg T; Højberg M; Gram J; Bech M; Brixen K; Hermann AP; Glüer CC; Barkmann R; Rubin KH
    Osteoporos Int; 2017 Dec; 28(12):3389-3399. PubMed ID: 28875257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis and treatment of pediatric osteoporosis.
    Bachrach LK
    Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):454-60. PubMed ID: 25232753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.